Veterinary Medicines Pharmacovigilance Annual Review 2019: Summary
A summary of results from surveillance work carried out by the VMD's pharmacovigilance team concerning reported adverse events.
Highlights of the key results from the Veterinary Medicines Pharmacovigilance Annual Review 2019.
The annual review summarises the 7,118 UK adverse events in animals, humans and the environment after use of veterinary medicines and other products reported to VMD in 2019.
These reports resulted in improvements to 55 of the medicine information leaflets included with animal medicines making the products safer to use and giving better information to users of medicines.
Information describing the clinical signs (symptoms) observed following use of different types of veterinary medicine can be accessed through the VMD’s adverse events dashboard.